Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-05

Clinical Trial Update: Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the effect of renin-angiotensin system blockers on glomerular filtration rate in adults with hypertension and type 2 di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Renin-angiotensin system blockers (RAS blocker)

Snippet

Sponsor: Hospital Authority, Hong Kong | Conditions: Diabetes, Hypertensive Disease | Phase 4 | Status: UNKNOWN